drugset / Trial / NCT06164743
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, double-masked, randomized, vehicle-controlled, parallel-comparison study conducted at sites in the United States (US) in subjects undergoing routine unilateral cataract extraction and lens replacement (CELR) surgery via phacoemulsification
Timeline
- Start
- 2024-01-11
- Primary completion
- 2024-05-15
- Completion
- 2024-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VVN461 | Unknown | 0.5 % | Topical |
| Subject | VVN461 | Unknown | 1 % | Topical |
Indications
No indication recorded.